Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma
- 1 March 2002
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 9 (3), 254-259
- https://doi.org/10.1038/sj.cgt.7700431
Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The prognosis of HCC is poor and current therapies are largely ineffective. Genetic abnormalities are commonly seen in HCC tumors particularly with inactivation of the p53 tumor suppressor. Gene therapy with E1B-deleted (dl1520) adenovirus could be of therapeutic value as it offers the potential of tumor growth control in patients with p53 mutation. Ten patients with posthepatitis cirrhosis and histologically proven HCC were enrolled into an open label, randomized prospective study. Randomization was to receive either percutaneous ethanol injection (control group) or dl1520. Toxicity and complications in the ethanol group were pain and fever, whereas in the gene therapy group complications were minimal. Grade I–II toxicity fever, stable performance status, and no significant rise in liver enzymes were observed in patients treated with dl1520. Analysis of patients' response to treatment in the gene therapy group showed one patient with a partial response and four patients with progressive disease. In the ethanol-treated group two patients had stable disease and three patients showed disease progression. In conclusion, this study showed that the adenovirus was well tolerated, but did not seem to offer significant tumor control. Although only a small number of patients were treated here it appears that more effective vectors are needed to achieve a useful clinical impact.Keywords
This publication has 17 references indexed in Scilit:
- E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver TumorsHuman Gene Therapy, 2001
- Electron Microscopic Assessment of Adenovirus-Mediated TransferPublished by Springer Science and Business Media LLC ,1999
- Clinical short-term results of radiofrequency ablation in primary and secondary liver tumorsThe American Journal of Surgery, 1999
- Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant MesotheliomaHuman Gene Therapy, 1998
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Surgical resection for small hepatocellular carcinomaSurgery, 1996
- Bile formation: Transport and cholestasisHepatology, 1995
- Tumor Suppressor GenesScience, 1991
- The Molecular Genetics of CancerScience, 1987
- Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfectionVirology, 1987